N-acetylcysteine Protects From Aminoglycosides Induced Nephrotoxicity
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
This randomized, double-blind, placebo-controlled clinical trial will be performed to assess
the effect of N-acetylcysteine therapy on the incidence of nephrotoxicity among patients
hospitalized with an infection and treated with aminoglycosides (AGs). Secondary goals of the
study will be as follows: comparison of the mortality rates, and length of hospitalization
among patients treated with N-acetylcysteine compared to the control group.